Assembly Biosciences
Develops antiviral and liver-disease candidates through discovery and clinical development.
$34.07
After-hours close+0.08 (+0.24%)
At close$33.99(−2.33%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.62 | — | — |
| Aug 2026 | −$0.72 | −$0.20 | +72.4% |
| May 2026 | −$0.73 | −$0.54 | +26.0% |
| Mar 2026 | −$0.51 | $2.48 | +586.3% |
| Nov 2025 | −$0.50 | −$0.72 | −44.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$0.62 | — | — | $7.9M | — | — |
| Aug 13, 2026 | −$0.72 | −$0.20 | +72.4% | $8.6M | $13.4M | +55.5% |
| May 7, 2026 | −$0.73 | −$0.54 | +26.0% | $9.3M | $8.2M | −11.4% |
| Mar 19, 2026 | −$0.51 | $2.48 | +586.3% | $7.4M | $42.5M | +472.2% |
| Nov 10, 2025 | −$0.50 | −$0.72 | −44.0% | $7.5M | $10.8M | +44.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 8, 2025 | ||||||
| Mar 20, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 8, 2024 | ||||||
| Mar 27, 2024 | ||||||
| Nov 8, 2023 | ||||||
| Aug 9, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 22, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 12, 2022 | ||||||
| Mar 10, 2022 | ||||||
| Nov 4, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 6, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 5, 2020 | ||||||
| May 7, 2020 | ||||||
| Mar 4, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 5, 2019 | ||||||
| May 9, 2019 | ||||||
| Feb 28, 2019 | ||||||
| Nov 8, 2018 | ||||||
| Aug 8, 2018 | ||||||
| May 7, 2018 | ||||||
| Mar 8, 2018 | ||||||
| Nov 1, 2017 | ||||||
| Aug 9, 2017 | ||||||
| May 8, 2017 | ||||||
| Mar 2, 2017 | ||||||
| Nov 9, 2016 | ||||||
| Aug 9, 2016 | ||||||
| May 10, 2016 | ||||||
| Mar 11, 2016 | ||||||
| Nov 9, 2015 | ||||||
| Aug 13, 2015 | ||||||